Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydr o-N-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydr o-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders

Details for Australian Patent Application No. 2012202991 (hide)

Owner Sunovion Pharmaceuticals Inc.

Inventors Wilkinson, H. Scott; Caron, Judy; Lalji, Karim; Varney, Mark; Han, Zhengxu; Koenig, Stefan G.; Singh, Surendra P.; Wessel, Thomas; Su, Xiping; Bakale, Roger P.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012202991

Parent 2006264317

Filing date 22 May 2012

Wipo publication date 14 June 2012

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

Event Publications

7 June 2012 Complete Application Filed

14 June 2012 Application Open to Public Inspection

  Published as AU-A-2012202991

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202992-Starting device for a competitor in a sports competition

2012202990-Tubing assembly and signal generator placement control device and method for use with catheter guidance systems